Cancer Family
Solid Neoplasm
CI-CAN-00000052Explore in graph →
Non-malignant1,822 active trials28 evidence items
- NCIt
- C9292
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000052Explore in graph →
Clinical trials
6,088 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00249977 | Phase I Study of Capecitabine in Combination With Cisplatin and Irinotecan | completed | Phase 1 | 21 | University of New MexicoOTHER | 1 | Jan 7, 2010 | clinicaltrials |
| NCT00005077 | Oxaliplatin in Treating Patients With Advanced Cancer Plus Liver Dysfunction | completed | Phase 1 | — | City of Hope Medical CenterOTHER | 1 | Jan 6, 2010 | clinicaltrials |
| Flavopiridol and Irinotecan in Treating Patients With Advanced Solid Tumors |
| completed |
| Phase 1 |
| — |
| Memorial Sloan Kettering Cancer CenterOTHER |
| 1 |
| Dec 15, 2009 |
| clinicaltrials |
| NCT00004877 | BMS-214662 in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Dec 3, 2009 | clinicaltrials |
| NCT00487058 | A Phase I Dose Escalation Study of LBQ707 (Gimatecan) Administered Orally Twice Per Week to Japanese Patients With Advanced Solid Tumors | completed | Phase 1 | 28 | NovartisINDUSTRY | 1 | Nov 19, 2009 | clinicaltrials |
| NCT00520637 | A Phase I, Study to Evaluate the Safety and Tolerability of Intravenous EZN-2208 in Patients With Advanced Solid Tumors or Lymphoma (EZN-2208-01) | completed | Phase 1 | 34 | Enzon Pharmaceuticals, Inc.INDUSTRY | 1 | Oct 9, 2009 | clinicaltrials |
| NCT00509613 | Phase 1 Study With Sorafenib and Sirolimus | completed | Phase 1 | — | Radboud University Medical CenterOTHER | 1 | Sep 18, 2009 | clinicaltrials |
| NCT00004923 | Docetaxel and Irinotecan in Treating Patients With Advanced Solid Tumors | completed | Phase 1 / Phase 2 | 47 | Yale UniversityOTHER | 1 | Aug 25, 2009 | clinicaltrials |
| NCT00037804 | Irinotecan in Treating Patients With Refractory Solid Tumors and Liver Dysfunction | completed | Phase 1 | — | PfizerINDUSTRY | 1 | Aug 14, 2009 | clinicaltrials |
| NCT00955786 | Dose-escalation Study of CX-3543 in Patients With Advanced Solid Tumors or Lymphomas | completed | Phase 1 | 48 | Cylene PharmaceuticalsINDUSTRY | 1 | Aug 10, 2009 | clinicaltrials |
| NCT00091806 | Two Dose Schedules of Panitumumab in Subjects With Advanced Solid Tumors | completed | Phase 1 | 86 | AmgenINDUSTRY | 0 | Jul 10, 2009 | clinicaltrials |
| NCT00503477 | A Phase I Open Label Dose Escalation Study for the Safety and Tolerability of AZD2171 in Solid Tumors in Japan | completed | Phase 1 | 40 | AstraZenecaINDUSTRY | 1 | Jun 12, 2009 | clinicaltrials |
| NCT00881244 | Study of AS1411 in Advanced Solid Tumours | completed | Phase 1 | 30 | Antisoma ResearchINDUSTRY | 1 | Apr 15, 2009 | clinicaltrials |
| NCT00863733 | Study of DMXAA (Now Known as ASA404) in Solid Tumors(DMXAA) | completed | Phase 1 | 63 | Cancer Research UKOTHER | 0 | Mar 18, 2009 | clinicaltrials |
| NCT00116896 | Phase I Study of Cisplatin Plus OSI-7904L in Patients With Solid Tumors | completed | Phase 1 | 25 | OSI PharmaceuticalsINDUSTRY | 1 | Jan 21, 2009 | clinicaltrials |
| NCT00712504 | Study Of SU011248 In Combination With Docetaxel In Patients With Advanced Cancer | completed | Phase 1 | 49 | PfizerINDUSTRY | 1 | Nov 11, 2008 | clinicaltrials |
| NCT00003705 | BMS-184476 in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | — | San Antonio Cancer InstituteOTHER | 1 | Jul 24, 2008 | clinicaltrials |
| NCT00043095 | BMS-247550 and Gemcitabine in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jul 24, 2008 | clinicaltrials |
| NCT00100958 | Indole-3-Carbinol in Preventing Cancer in Healthy Participants | completed | Phase 1 | — | University of KansasOTHER | 1 | Jul 24, 2008 | clinicaltrials |
| NCT00394446 | Phase 1, Multiple Dose Study of MPC-6827 in Subjects With Refractory Solid Tumors | completed | Phase 1 | 48 | Myrexis Inc.INDUSTRY | 1 | Feb 13, 2008 | clinicaltrials |
Data updated 22 days agoSource updated Jan 7, 2010source: clinicaltrials